Cellnovo Stock

Stocks

CLNV

FR0012633360

Software

Real-time Euronext Paris 5-day change 1st Jan Change
- EUR -.--% Intraday chart for Cellnovo -.--% -

Valuation: Cellnovo

Market Cap 2.44M 2.12M 1.97M 1.81M 3.42M 233M 3.47M 23.23M 9.12M 116M 9.15M 8.95M 388M P/E 2018 *
-0.15x
P/E 2019 * -
Enterprise Value 12.46M 10.83M 10.08M 9.25M 17.48M 1.19B 17.75M 119M 46.63M 592M 46.79M 45.76M 1.99B EV / Sales 2018
8.63x
EV / Sales 2019 * -
Free-Float
99.67%
Yield 2018 *
-
Yield 2019 * -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 2.68M
+1.32%+3.35% - - 22.07B
-0.28%+1.14%-29.62%-5.85% 16B
0.00%+7.82%-50.27%-58.71% 7.89B
+5.78%+15.91%+20.89%+110.04% 7.75B
-1.99%+6.30%-34.09%+236.93% 4.46B
+4.77%+6.20%-34.15%-14.31% 2.38B
+4.63%+8.78%-33.45%-34.58% 1.91B
+0.46%+7.49%+29.82%+90.80% 1.62B
-1.44%+2.55%+2.89%+44.11% 1.45B
Average +1.39%+4.62%-16.00%+46.05% 6.55B
Weighted average by Cap. +1.26%+2.23%-21.93%+33.68%

Financials

2018 2019 *
Net sales 3.32M 2.89M 2.69M 2.47M 4.66M 317M 4.73M 31.68M 12.43M 158M 12.48M 12.2M 529M -
Net income -15.94M -13.86M -12.9M -11.84M -22.36M -1.52B -22.71M -152M -59.66M -757M -59.86M -58.55M -2.54B -
Net Debt 10.02M 8.71M 8.11M 7.45M 14.06M 957M 14.28M 95.59M 37.52M 476M 37.64M 36.81M 1.6B -
Logo Cellnovo
Cellnovo Group SA is a France-based company principally engaged in medical instrument manufacturing . The Company specialized in the development of a mobile system for managing type 1 diabetes. Its apparatus includes a cordless micro-pump (a patch pump), an integrated monitoring device and a cellular handset with touch screen with an embedded blood glucose meter. The Company system enables diabetics to live a normal life whilst closely monitoring their glycaemia, their use of insulin, their activity and their food intake.
Employees
-
  1. Stock Market
  2. Stocks
  3. CLNV Stock